AustralianSuper Pty Ltd Acquires New Holdings in Ryan Specialty Holdings Inc. $RYAN

AustralianSuper Pty Ltd bought a new position in shares of Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 226,397 shares of the company’s stock, valued at approximately $12,760,000. AustralianSuper Pty Ltd owned approximately 0.09% of Ryan Specialty as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of RYAN. Vanguard Personalized Indexing Management LLC increased its position in shares of Ryan Specialty by 20.5% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 11,417 shares of the company’s stock worth $644,000 after acquiring an additional 1,939 shares in the last quarter. LBP AM SA acquired a new position in Ryan Specialty in the 3rd quarter worth $2,660,000. Whittier Trust Co. of Nevada Inc. increased its holdings in Ryan Specialty by 83.7% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company’s stock worth $35,000 after purchasing an additional 273 shares in the last quarter. Retirement Systems of Alabama raised its stake in shares of Ryan Specialty by 3.5% in the 3rd quarter. Retirement Systems of Alabama now owns 136,231 shares of the company’s stock valued at $7,678,000 after purchasing an additional 4,663 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH raised its stake in shares of Ryan Specialty by 20.4% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 650,796 shares of the company’s stock valued at $36,679,000 after purchasing an additional 110,207 shares during the period. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Price Performance

Shares of RYAN opened at $47.23 on Friday. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 2.72. The company’s fifty day simple moving average is $52.76 and its 200 day simple moving average is $55.56. Ryan Specialty Holdings Inc. has a 1-year low of $46.18 and a 1-year high of $77.16. The company has a market cap of $12.46 billion, a price-to-earnings ratio of 102.68, a PEG ratio of 1.20 and a beta of 0.63.

Ryan Specialty (NYSE:RYANGet Free Report) last announced its quarterly earnings data on Thursday, October 30th. The company reported $0.47 EPS for the quarter, meeting analysts’ consensus estimates of $0.47. The company had revenue of $754.58 million during the quarter, compared to the consensus estimate of $742.35 million. Ryan Specialty had a net margin of 7.61% and a return on equity of 47.93%. The company’s quarterly revenue was up 24.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.41 EPS. On average, research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

RYAN has been the subject of a number of research reports. Keefe, Bruyette & Woods decreased their price objective on Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Barclays lowered their price objective on shares of Ryan Specialty from $65.00 to $58.00 and set an “overweight” rating on the stock in a report on Thursday, January 8th. UBS Group reduced their target price on shares of Ryan Specialty from $80.00 to $75.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Morgan Stanley set a $61.00 target price on shares of Ryan Specialty in a research report on Tuesday, December 16th. Finally, Mizuho set a $60.00 price target on shares of Ryan Specialty in a research report on Wednesday, January 14th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $64.19.

Check Out Our Latest Stock Report on Ryan Specialty

Insider Buying and Selling

In other Ryan Specialty news, CEO Timothy William Turner sold 129,570 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the transaction, the chief executive officer owned 12,553 shares of the company’s stock, valued at $672,966.33. The trade was a 91.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 52.21% of the company’s stock.

About Ryan Specialty

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.